Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 212-762-3 | CAS number: 867-56-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Developmental toxicity / teratogenicity
Administrative data
- Endpoint:
- developmental toxicity
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 1995-12-08 to 1999-12-06
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 999
- Report date:
- 1999
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 414 (Prenatal Developmental Toxicity Study)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Limit test:
- no
Test material
- Reference substance name:
- 2-ethylhexyl lactate
- EC Number:
- 228-503-2
- EC Name:
- 2-ethylhexyl lactate
- Cas Number:
- 6283-86-9
- Molecular formula:
- C11H22O3
- IUPAC Name:
- 2-ethylhexyl 2-hydroxypropanoate
Constituent 1
- Specific details on test material used for the study:
- - Name of test material (as cited in study report): 2-Ethylhexyl lactate
- Molecular formula (if other than submission substance): C11H22O3
- Molecular weight (if other than submission substance): 202.3 g/mol
- Physical state: Clear, colourless liquid
- Analytical purity: 98.2 %
- Lot/batch No.: EHL 951116-2
- Thermostability: Stable at ambient temperature
TREATMENT OF TEST MATERIAL PRIOR TO TESTING . The generated mixture of test material and air was subsequently mixed with meterd amounts of pressurized air and was again mixed at the entrance of the exposure unit with metered amounts of humidified pressurized air.
Test animals
- Species:
- rat
- Strain:
- Wistar
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Harlan Winkelmann GmbH, Borchen, Germany
- Age at study initiation: 10-11 weeks
- Weight at study initiation: No data
- Fasting period before study: No
- Housing: during acclimatization period: In groups of four in suspended stainless group cages; shortly before mating, males were housed individually in smaller suspended wire mesh cages with wire mesh floor and front; mated females were housed individually in wire mesh cages before and after exposure; during the daily 6-hour exposure period (day 6-15 of gestation) the female rats were individually placed in inhalation tubes
- Diet (e.g. ad libitum): TNO rodent diet batch 2020, ad libitum
- Water (e.g. ad libitum): tap water, ad libitum
- Acclimation period: 6 days quarantine, afterwards 13 days acclimation
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 3
- Humidity (%): 30-70
- Air changes (per hr): 10
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: 1996-02-07 to 1996-03-20
Administration / exposure
- Route of administration:
- inhalation: aerosol
- Type of inhalation exposure (if applicable):
- nose only
- Vehicle:
- clean air
- Mass median aerodynamic diameter (MMAD):
- > 1.7 - < 2.7 µm
- Geometric standard deviation (GSD):
- 1.55
- Details on exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: nose-only inhalation units consisting of a cylindrical Teflon-coated steel column surrounded by a transparent cylinder. The column had a volume of 50 L and consisted of a top assembly, with two rodent tube sections underneath and an exhaust section at the bottom. The rodent tube section had 40 ports for animal exposure
- Method of holding animals in test chamber: the animals were secured in plastic animal holders, positioned radially through the outer cylinder around the central column
- Source and rate of air: see below
- System of generating particulates/aerosols: The inhalation equipment was designed to expose rats to a continuous supply of fresh test atmosphere. Each test atmosphere was generated separately. The low-concentration test atmosphere was generated by passing metered amounts of the test material using a roller pump (Gilson, Villiers le Bel, France) to a compressed air driven, all glass nebulizer (Institute's design). The generated mixture of test material and air was subsequently mixed with metered amounts of pressurized air (using a rotameter) and was again mixed at the entrance of the
exposure unit with metered amounts of humidified pressurized air (using a second rotameter). The resulting test atmosphere was directed downwards through the mixing chamber towards the animal's noses. The test atmosphere was exhausted at the bottom of the unit. The high-concentration test atmosphere was generated by nebulizing the test material using compressed air driven steel nebulizers (Institute's design). These nebulizers consisted of an atomizer (Lechler Informatie Buro Holland, Oudorp, the Netherlands) and a glass jar containing the test material. During operation, the test material was drawn through a suction tube to the atomizer and was blown against a baffle which was fitted below the nozzle orifice in such a way that the larger droplets were removed by impaction. The impacted test material drained back into the test material supply at the bottom of the jar. The resulting aerosol was also mixed with humidified pressurized air in the way described above and also directed towards the animals.
- Temperature, humidity, pressure in air chamber: several empty ports of the rodent tube section were used for temperature and relative humidity measurements
- Air flow rate: Before the start of the first exposure, the rate of airflow through the nebulizers was established at the pressures used. The pressure settings were recorded at regular intervals (approximately hourly). In this way, the total exposure airflows were monitored indirectly through the aerosol generation system.
- Method of particle size determination: Particle size distribution measurement was carried out in each test atmosphere (except for the control test atmosphere) once per week using an 11-stage cascade impactor with a largest cut off size of 4.2 µm. The Mass Median Aerodynamic Diameter (MMAD) and the mean geometry standard deviation (gsd) were calculated.
TEST ATMOSPHERE
- Brief description of analytical method used: The actual concentration of 2-ethylhexyl lactate in the test atmosphere was determined at least 3 times per exposure day by means of gravimetric analysis. Measured test atmosphere samples were obtained by passing approximately 50 or 30 liters test atmosphere for the low- and high-concentration level, respectively, at a mean sampling speed of ca 5 L/min, through fibre glass filters.
Before and immediately after sampling the filters were weighed. The actual concentration was calculated by dividing the amount of test material on the filter by the sample volume. - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- The actual concentration of 2-ethylhexyl lactate in the test atmosphere was determined at least three times per exposure day by means of gravimetric analysis.
- Details on mating procedure:
- - Impregnation procedure: Co-housed
- M/F ratio per cage: 1/2
- Length of cohabitation: Upon evidence of copulation, positive females were housed individually
- Proof of pregnancy: Vaginal plug/sperm in vaginal smear referred to as day 0 of pregnancy - Duration of treatment / exposure:
- From day 6 up to day 15 of gestation daily six hours exposure sessions.
- Frequency of treatment:
- Daily
- Duration of test:
- After termination of the exposure period, the rats were observed up to gestation day 21.
Doses / concentrationsopen allclose all
- Dose / conc.:
- 200 mg/m³ air (nominal)
- Remarks:
- chosen on the basis of similar studies with ethyl lactate (NOAEL)
- Dose / conc.:
- 230 mg/m³ air (analytical)
- Dose / conc.:
- 600 mg/m³ air (nominal)
- Remarks:
- chosen on the basis of similar studies with ethyl lactate (highest dose without adverse systemic effects)
- Dose / conc.:
- 594 mg/m³ air (analytical)
- No. of animals per sex per dose:
- 12
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- - Dose selection rationale: Doses were based on similar studies with ethyl lactate showing moderate lo severe nasal irritating and toxic (local) effects at levels of 600 and 2500 mg/m³, whereas slight systemic toxicity (reduced food consumption and growth retardation) was observed at the 2500 mg/m³ level only. The no-observed-adverse-effect level (NOAEL) in these studies was 200 mg/m³.
Examinations
- Maternal examinations:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: On the weekend once a day, on working days twice a day
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: Each mated female was observed daily from gestation day 0 and, if necessary, handled to appraise its physical condition. Signs of ill health and reaction to treatment as well as mortality were recorded.
BODY WEIGHT: Yes
- Time schedule for examinations: Body weights of the mated female rats were recorded on gestation days 0, 6, 10, 15 and 21.
FOOD CONSUMPTION: Yes
- Food consumption of mated females was measured for each animal individually by weighing the feeders on days 0, 6, 10, 15 and 21 of gestation.
WATER CONSUMPTION: No
POST-MORTEM EXAMINATIONS: Yes
- Sacrifice on gestation day 21; gross abnormalities were examined - Ovaries and uterine content:
- The ovaries and uterine content was examined after termination: Yes
Examinations included:
- Gravid uterus weight: Yes
- Number of corpora lutea: Yes
- Number of implantations: Yes
- Number of early resorptions: Yes
- Number of late resorptions: Yes - Fetal examinations:
- Half of the foetuses of each litter were fixed in Boum's fixative, examined for soft tissue anomalies according to a method modified after Barrow and Taylor (1969) and then discarded. The other half of the fetuses were fixed in 70 % alcohol, subsequently partly eviscerated, and then cleared in potassium hydroxide and stained with Alizarin Red S modified after Dawson (1926). They were examined for skeletal abnormalities and then retained.
The foeto-pathological examinations were initially restricted to all foetuses of the control group and the high-concentration group. As some alterations were found in the ossification of the skeletons in the latter group the skeletal examinations were extended to the intermediate dose group, after consultation with the Sponsor. - Statistics:
- Adult data:
Clinical and necropsy findings were evaluated by Fisher's exact probability test. Body weight, body weight gain, organ weights and food consumption data were
be subjected to one-way analysis of variance (ANOVA) followed by Dunnett's multiple comparison tests.
Mating, Caesarian section and litter data:
Fisher's exact probability test was used to evaluate foetal external, visceral and skeletal observations, the number of mated and pregnant females, females with
live foetuses and male and female foetuses. Number of corpora lutea, implantations, live and dead foetuses and early and late resorptions were evaluated by Kruskal-Wallis nonparametric analysis of variance followed by the Mann-Whitney U-test. Placental and foetal weight were evaluated by one-way analysis of variance (ANOVA) followed by Dunnett's multiple comparison tests. - Indices:
- The following indices were calculated for each group at the Caesarian section: Pre-implantation loss, post-implantation loss, fecundity index, gestation index, live foetus index, sex ratio.
- Historical control data:
- N.A.
Results and discussion
Results: maternal animals
General toxicity (maternal animals)
- Clinical signs:
- effects observed, non-treatment-related
- Description (incidence and severity):
- Abnormalilics seen during exposure were confined to visually increased breathing rate in animals exposed lo 600 mg/m³ during Ihe entire treatment period and occasionally in rats exposed lo 200 mg/m3. One animal of the control group (A 101) lost part of its tail due to a mechanical trauma. Daily clinical observations did not reveal any noticeable differences in the animals' appearance, general condition or behaviour amongst the various groups.
- Dermal irritation (if dermal study):
- not examined
- Mortality:
- mortality observed, non-treatment-related
- Description (incidence):
- One animal of the low dose group died on day 11 of gestation because it turned around in the inhalation tube and subsequently suffocated. All other females survived until scheduled Caesarian section.
- Body weight and weight changes:
- no effects observed
- Description (incidence and severity):
- There were no significant differences in body weight or body weight change between the control group and the groups exposed to the test substance.
- Food consumption and compound intake (if feeding study):
- effects observed, treatment-related
- Description (incidence and severity):
- The food consumption of the high dose group was statistically significantly decreased when compared to the control group throughout the exposure period. The food consumption of the 200 mg/m³ was slightly decreased during the exposure period, but increased thereafter.
- Food efficiency:
- not specified
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- not examined
- Clinical biochemistry findings:
- not examined
- Urinalysis findings:
- not examined
- Behaviour (functional findings):
- no effects observed
- Immunological findings:
- not examined
- Organ weight findings including organ / body weight ratios:
- not examined
- Gross pathological findings:
- no effects observed
- Description (incidence and severity):
- Gross examination at autopsy did not reveal any significant differences of the maternal organs and tissues among the various groups.
- Neuropathological findings:
- not examined
- Histopathological findings: non-neoplastic:
- not examined
- Histopathological findings: neoplastic:
- not examined
- Other effects:
- no effects observed
- Description (incidence and severity):
- Uterus and ovary weights:
Mean reproductive organ weights and net maternal body weight change during gestation were evaluated. No statistically significant differences in gravid and empty uterus weight, ovary weight, carcass weight and the net weight change (body weight gain from day 0 to 21 of gestation minus gravid uterine weight) were observed between the control group and he groups treated to 2-ethylhexyl lactate.
Maternal developmental toxicity
- Number of abortions:
- no effects observed
- Pre- and post-implantation loss:
- no effects observed
- Description (incidence and severity):
- There were no statistically significant differences between the control group and the groups exposed to the test substance in the numbers of corpora lutea, implantations, live and dead foetuses and early and late resorptions nor in pre- and post-implantation loss or in the sex ratio of the foetuses.
- Total litter losses by resorption:
- no effects observed
- Description (incidence and severity):
- There were no statistically significant differences between the control group and the groups exposed to the test substance in the numbers of corpora lutea, implantations, live and dead foetuses and early and late resorptions nor in pre- and post-implantation loss or in the sex ratio of the foetuses.
- Early or late resorptions:
- no effects observed
- Description (incidence and severity):
- There were no statistically significant differences between the control group and the groups exposed to the test substance in the numbers of corpora lutea, implantations, live and dead foetuses and early and late resorptions nor in pre- and post-implantation loss or in the sex ratio of the foetuses.
- Dead fetuses:
- no effects observed
- Description (incidence and severity):
- There were no statistically significant differences between the control group and the groups exposed to the test substance in the numbers of corpora lutea, implantations, live and dead foetuses and early and late resorptions nor in pre- and post-implantation loss or in the sex ratio of the foetuses.
- Changes in pregnancy duration:
- not examined
- Changes in number of pregnant:
- no effects observed
- Description (incidence and severity):
- From the 12 mated female rats per group, 11 of each group were pregnant.
- Other effects:
- not examined
- Details on maternal toxic effects:
- Details on maternal toxic effects:
Clinical signs and mortality:
One animal of the low dose group died on day 11 of gestation because it turned around in the inhalation tube and subsequnetly suffocated. Daily clinical observations did not reveal any differences between dose and control group animals.
Maternal body weight and body weight change:
There were no significant differences in body weight or body weight change between the control group and the groups exposed to the test substance.
Food consumption:
The food consumption of the high dose group was statistically significantly decreased when compared to the control group throughout the exposure period. The food consumption of the 200 mg/m³ was slightly decreased during the exposure period, but increased thereafter.
Parental necropsy observations:
Gross examination at autopsy did not reveal any significant differences of the maternal organs and tissues among the various groups.
Uterus and ovary weights:
Mean reproductive organ weights and net maternal body weight change during gestation were evaluated. No statistically significant differences in gravid and empty uterus weight, ovary weight, carcass weight and the net weight change (body weight gain from day 0 to 21 of gestation minus gravid uterine weight) were observed between the control group and the groups treated to 2-ethylhexyl lactate.
Effect levels (maternal animals)
- Key result
- Dose descriptor:
- NOAEC
- Effect level:
- 600 mg/m³ air (nominal)
- Based on:
- test mat.
- Basis for effect level:
- other: No differences in clinical signs, maternal body weight or body weight change and necropsy seen in treated animals in comparison to control animals.
Maternal abnormalities
- Key result
- Abnormalities:
- no effects observed
Results (fetuses)
- Fetal body weight changes:
- no effects observed
- Description (incidence and severity):
- See box “Details on embryotoxic / teratogenic effects” below.
- Reduction in number of live offspring:
- no effects observed
- Changes in sex ratio:
- no effects observed
- Changes in litter size and weights:
- effects observed, treatment-related
- Description (incidence and severity):
- See box “Details on embryotoxic / teratogenic effects” below.
- Changes in postnatal survival:
- not examined
- External malformations:
- no effects observed
- Description (incidence and severity):
- See box “Details on embryotoxic / teratogenic effects” below.
- Skeletal malformations:
- no effects observed
- Description (incidence and severity):
- See box “Details on embryotoxic / teratogenic effects” below.
- Visceral malformations:
- no effects observed
- Description (incidence and severity):
- See box “Details on embryotoxic / teratogenic effects” below.
- Other effects:
- not specified
- Details on embryotoxic / teratogenic effects:
- Details on embryotoxic / teratogenic effects:
Reproduction and litter data at Caesarian section:
From the 12 mated female rats per group, 11 of each group were pregnant.
Reproduction and litter data revealed no treatment-related changes either as evidenced by the absence of statistically significant differences between the
control group and the groups exposed to the test substance in the numbers of corpora lutea, implantations, live and dead foetuses and early and late resorptions nor in pre- and
post-implantation loss or in the sex ratio of the foetuses.
Foetal external observations:
No statistically significant differences were observed for the individual findings. When compared with the control group, the total number of fetal external
observations was slightly albeit statistically significantly increased in the high concentration group. This difference was mainly due to the low number of foetal
observations in the control group: Only one foetus with a small haemorrhage on the head in the control group versus 4 dysmature foetuses from 4 litters (i.e. foetus weight < 75 % of the mean foetal body weight in the control group) and three large foetuses (i.e. foetus weight > 125 % of the mean foetal body weight) plus one foetus with a flexed limb from one litter of the 600 mg/m³ group. Considering the nature of the findings and the low number in the control group, this difference is not considered treatment related.
Findings of the placenta:
Findings of the placenta were limited to two fused placenta in four fetuses of one female control group animal.
Foetal weight and placental weight:
No significant differences in mean foetal body weights were observed between the control group and the groups exposed to the test substance. Mean placental
weight of the 200 mg/m³ group was increased (statistically significantly for both sexes combined). Mean placental weights in of the 600 mg/m³ were comparable to these in the control group.
Visceral examination:
Examination of foetal soft tissues was limited to the control group and the high concentration group.
Visceral malformations:
No visceral malformations were seen in the control group and the high concentration group.
Visceral anomalies:
No visceral variations were observed in the control and the high-concentration group.
Skeletal examinations:
Skeletal examinations were conducted in all groups.
Skeletal malformations:
None of the fetuses showed skeletal malformations
Skeletal anomalies:
Skeletal anomalies were limited to wavy ribs in 3 foetuses out of 2 litters in the high-concentration groups. The incidence in the high-concentration group did not differ significantly from that in the control group.
Skeletal variations:
No statistically significant differences were observed for the individual findings.
Variations in the ossification of the skeletons
When compared with the control group, the 200 and 600 mg/m³ groups showed the following differences: Increase in the number of foetuses and litters with an incompletely ossified frontalis and unossified metatarsals, which was significant in the 200 mg/m³ group. Furthermore, a delay in the ossification of the hind limb phalanges was observed in the 200 and 600 mg/m³ group. The slightly retarded ossification as observed at 200 and 600 mg/m3, was considered to be a minor developmental effect, most attributable to the stress conditions. No teratogenic effects were observed in this study.
Effect levels (fetuses)
- Key result
- Dose descriptor:
- NOAEC
- Effect level:
- 600 mg/m³ air (nominal)
- Based on:
- test mat.
- Basis for effect level:
- other: developmental toxicity
Fetal abnormalities
- Key result
- Abnormalities:
- no effects observed
Overall developmental toxicity
- Developmental effects observed:
- no
Any other information on results incl. tables
Gravimetric analysis:
The mean actual concentrations of 2-ethylhexyl lactate in the test atmospheres (and their standard deviations) were 230 (± 16) and 594 (± 48) mg/m³.
Nominal concentration:
The daily mean airflow through the exposure units were 26.5, 55.9, and 70.4 L/min for the control, low, and high concentration level, respectively. The nominal concentrations were 378 and 751 mg/m³, indicating generation efficiencies of 61 and 79 % for the low and high concentration level, respectively.
Particle size measurement:
Particle size measurement showed that almost all particles in the animals' breathing zone were respirable, viz. they were smaller than or equal to 4.2 µm. The mean mass median aerodynamic siameter (MMAD) was 2.7 and 1.7 µm for the low and high exposure level, respectively. The mean geometric standard deviation was 1.5 for the low concentration level and 1.6 for the high concentration level.
Temperature and relative humidity:
The daily mean temperature was 22.7 ± 0.6 °C, 22.6 ± 0.4 °C and 22.6 ± 0.4 °C for the control, low and high concentration level. respectively. The daily relalive humidity was 56 ± 6%, 52 ± 5% and 52 ± 6 %, respectively.
Applicant's summary and conclusion
- Conclusions:
- In conclusion, no treatment-related effects in developmental parameters or maternal parameters were detected in a developmental toxicity study (OECD 414) after inhalation of 2-ethylhexyl lactate, except slightly retarded ossification. This is considered to be a minor developmental effect, most attributable to the stress conditions. Therefore, it can be stated that no teratogenic effects were observed in this study and the maternal and developmental NOAEC is considered to be 600 mg/m³.
- Executive summary:
In a developmental toxicity study (OECD 414), 2-ethylhexyl lactate (98.2% purity) was administered to 12 female Wistar rats per dose level in clean air (nose-only exposure for 6 hours/day) at concentration levels of 0, 200 and 600 mg/m³ from day 6 through day 15 of gestation. On day 21 of gestation the animals were sacrificed. There were no treatment-related effects on mortality, clinical signs, body weight or Casarean parameters. Food consumption of the groups was statistically significantly decreased in comparison to the control group animals. As no differences were noticed in body weight change between control and treated animals this effect was classified as not biologically adverse. Based on the results, the maternal NOAEC is considered to be 600 mg/m³. Moreover, no treatment related effects were noted in developmental parameters, except slightly retarded ossification. This is considered to be a minor developmental effect, most attributable to the stress conditions. Thus, the developmental NOAEC is 600 mg/m³.
This developmental toxicity study in the rat is classified acceptable and satisfies the guideline requirement for a developmental toxicity study (OPPTS 870.3700; OECD 414) in rat.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)